Akèy › Displazi vantrikil dwat aritmojenik
Etid klinik pou Displazi vantrikil dwat aritmojenik ap rekrite nan Etazini
8 etid pou Displazi vantrikil dwat aritmojenik ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
Pa eta
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Cardiovascular Multimodality Imaging Study
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 10, 2026 · NCT06610019Pediatric Cardiomyopathy Mutation Analysis
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jun 22, 2026 · NCT02432092Mayo AVC Registry and Biobank
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Tout laj · Tout sèks · Mizajou Apr 27, 2026 · NCT03049254A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM)
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Apr 16, 2026 · NCT05885412PKP2-ACM Natural History Study
Ap rekriteEtid obsèvasyon
Laj 12 ak plis · Tout sèks · Mizajou Feb 27, 2026 · NCT06644742A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-ACM
Ap rekriteEtid obsèvasyon
Laj 18 a 65 · Tout sèks · Mizajou May 16, 2025 · NCT06976606Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC
Ap rekriteFaz 1
Laj 18 a 65 · Tout sèks · Mizajou Feb 6, 2025 · NCT06228924Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
Ap rekriteEtid obsèvasyon
Laj 14 a 65 · Tout sèks · Mizajou Nov 1, 2024 · NCT06311708Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.